{"issuance_frequency":"","notes_translated":{"fr":"Cette ligne directrice a pour objet de fournir aux promoteurs une description des exigences relatives au contrôle de la qualité et à la fabrication, des exigences cliniques et des exigences relatives à l'innocuité humaine, qui doivent être satisfaites lors de la préparation et du dépôt des types de présentations suivantes à la Direction des médicaments vétérinaires (DMV): Présentation abrégée de drogue nouvelle (PADN); Changement à une PADN - Supplément à une présentation abrégée de drogue nouvelle (SPADN) et Modification à déclaration obligatoire (MDO).","en":"This guidance document is intended to provide sponsors with an outline of the chemistry and manufacturing, clinical, and human safety requirements for the filing of the following submission types with the Veterinary Drugs Directorate (VDD): Abbreviated New Drug Submission (ANDS); Changes to ANDS - Supplemental Abbreviated New Drug Submission (SANDS) and Notifiable Change (NC)."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"39cca0e6-2561-491b-a32b-e713eaf5cf43","metadata_created":"2021-07-08T13:11:39.870965","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-07-08T13:11:39.870972","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-07-08","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Lignes directrices à l'intention de l'industrie","présentations abrégées de drogue nouvelle à usage vétérinaire","préparation des présentations abrégées de drogue nouvelle à usage vétérinaire","présentation abrégée supplémentaire de drogue nouvelle","modification à déclaration obligatoire","médicaments génériques","chimie et fabrication","exigences en matière de sécurité clinique et humaine","Direction des médicaments vétérinaires"],"en":["Guidance for industry","veterinary abbreviated new drug submissions","preparation of veterinary abbreviated new drug submissions","supplemental abbreviated new drug submission","notifiable change","generic drugs","chemistry and manufacturing","clinical","and human safety requirements","Veterinary Drugs Directorate"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice à l'intention de l'industrie - Préparation des présentations abrégées de drogues nouvelles vétérinaires - Médicaments génériques","en":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"39cca0e6-2561-491b-a32b-e713eaf5cf43","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"62f13250-0fb5-46c3-a403-9b45c74644a8","related_relationship":"","name_translated":{"fr":"Ligne directrice à l'intention de l'industrie - Préparation des présentations abrégées de drogues nouvelles vétérinaires - Médicaments génériques","en":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs","language":["en"],"created":"2021-07-08T13:11:39.998384","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/veterinary-drugs/legislation-guidelines/guidance-documents/guidance-industry-preparation-veterinary-abbreviated-new-drug-submissions-generic-drugs-health-canada-2009-1.html#a1","last_modified":null,"position":0,"revision_id":"09001cd1-d618-4384-9392-7506613a7fa0","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"39cca0e6-2561-491b-a32b-e713eaf5cf43","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"b7df678c-9934-4a6b-936d-8e7f84614197","related_relationship":"","name_translated":{"fr":"Ligne directrice à l'intention de l'industrie - Préparation des présentations abrégées de drogues nouvelles vétérinaires - Médicaments génériques","en":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs","language":["fr"],"created":"2021-07-08T13:11:39.998391","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments-veterinaires/legislation-lignes-directrices/lignes-directrices/ligne-directrice-intention-industrie-preparation-presentations-abregees-drogues-nouvelles-veterinaires-medicaments-generiques-sante-canada-2009.html#a1","last_modified":null,"position":1,"revision_id":"09001cd1-d618-4384-9392-7506613a7fa0","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2010-02-08 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"39cca0e6-2561-491b-a32b-e713eaf5cf43","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This guidance document is intended to provide sponsors with an outline of the chemistry and manufacturing, clinical, and human safety requirements for the filing of the following submission types with the Veterinary Drugs Directorate (VDD): Abbreviated New Drug Submission (ANDS); Changes to ANDS - Supplemental Abbreviated New Drug Submission (SANDS) and Notifiable Change (NC).","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs","revision_id":"09001cd1-d618-4384-9392-7506613a7fa0"}